Veeva Systems Inc
NYSE:VEEV

Watchlist Manager
Veeva Systems Inc Logo
Veeva Systems Inc
NYSE:VEEV
Watchlist
Price: 239.05 USD -1.22% Market Closed
Market Cap: 39.2B USD

Veeva Systems Inc
Other Long-Term Assets

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Veeva Systems Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Veeva Systems Inc
NYSE:VEEV
Other Long-Term Assets
$372.8m
CAGR 3-Years
32%
CAGR 5-Years
40%
CAGR 10-Years
53%
Inspire Medical Systems Inc
NYSE:INSP
Other Long-Term Assets
$17.3m
CAGR 3-Years
17%
CAGR 5-Years
112%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Other Long-Term Assets
$62.1m
CAGR 3-Years
7%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Other Long-Term Assets
$120m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
42%
Certara Inc
NASDAQ:CERT
Other Long-Term Assets
$6m
CAGR 3-Years
-1%
CAGR 5-Years
50%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Other Long-Term Assets
$89.4m
CAGR 3-Years
24%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Veeva Systems Inc
Glance View

Veeva Systems Inc., born in the heart of Silicon Valley in 2007, embarked on its journey with a clear mission: to revolutionize the pharmaceutical and life sciences industries with cloud-based solutions. Founded by Peter Gassner, who previously held leadership roles at Salesforce and PeopleSoft, Veeva identified a niche opportunity amid the highly-regulated, complex landscape of healthcare. The company began by offering Customer Relationship Management (CRM) software tailored for the life sciences sector, allowing clients to stay compliant with industry regulations while efficiently managing relationships across the intricate healthcare network. Veeva’s CRM solutions gradually became instrumental for pharmaceutical and biotech companies in conducting their marketing, sales, and collaboration activities. As Veeva expanded, it diversified its portfolio by delving into other digital solutions, such as data management and analytics, content management, and regulatory and compliance software. Its Vault platform stood out, providing a unified suite for managing a vast array of business processes and content across powerful cloud applications. This approach enabled Veeva to serve its clientele throughout the drug development lifecycle, from research and development to commercialization. By adopting a subscription-based pricing model, Veeva ensured a steady revenue stream while continuously enhancing its offerings, solidifying its position as both a trusted partner and a critical component of its clients’ operational infrastructure. Through these strategic expansions, Veeva Systems Inc. not only adapted to the evolving demands of the healthcare sector but also reinforced its dominance in the specialized domain of life sciences cloud technology.

VEEV Intrinsic Value
159.58 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Veeva Systems Inc's Other Long-Term Assets?
Other Long-Term Assets
372.8m USD

Based on the financial report for Oct 31, 2025, Veeva Systems Inc's Other Long-Term Assets amounts to 372.8m USD.

What is Veeva Systems Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
53%

Over the last year, the Other Long-Term Assets growth was -7%. The average annual Other Long-Term Assets growth rates for Veeva Systems Inc have been 32% over the past three years , 40% over the past five years , and 53% over the past ten years .

Back to Top